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QUESTION ASKED: What are the best practice recommendations for exercise programming for people with
bone metastases?
SUMMARY ANSWER: People with bone metastases
should be supported and encouraged to engage in
regular physical activity, including structured exercise,
to obtain the well-established general health beneﬁts
and as a strategy to manage side effects related to
cancer and treatments. Perceived risks of skeletal complications should be weighed against the potential health
beneﬁts in consultation between the person with bone
metatases, health care team, and exercise professional.
WHAT WE DID: The International Bone Metastases Exercise Working Group (IBMEWG) developed best practice
recommendations on the basis of published research,
clinical experience, and expert opinion using (1) modiﬁed
Delphi survey, (2) systematic review, (3) cross-sectional
survey to physicians and nurse practitioners, (4) inperson meeting, and (5) stakeholder engagement.
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WHAT WE FOUND: On the basis of the review of available
evidence and expert consensus, the IBMEWG developed ﬁve key recommendations: (1) Before exercise
testing or training, perform a risk assessment to inform
the likelihood of a skeletal complication from exercise.
(2) Consultation with the medical team is strongly encouraged to obtain key medical information and establish bidirectional communication. (3) Exercise
professionals best suited for this population are physical
therapists and clinical exercise physiologists (or equivalent) who have additional cancer exercise training. (4)
Professional judgement should be used to consider if
exercise testing is necessary. (5) Exercise prescription

should follow the standard exercise recommendations
as outlined by the International Exercise Guidelines for
Cancer Survivors, with greater emphasis on postural
alignment, controlled movement, proper technique, and
consideration of the bone lesion location and presentation.
BIAS, CONFOUNDING FACTORS: Some authors of this
paper are employed by entities that provide physical
activity programming for people with cancer, are involved in professional organizations that promote the
role of exercise professionals within health care settings, and/or were authors for the International Exercise Guidelines for Cancer Survivors. Although these
are strengths in terms of expertise, they may also lead
to bias.
REAL-LIFE IMPLICATIONS: Exercise has been underutilized in people with advanced or incurable cancer
despite the potential to improve physical function and
reduce psychosocial morbidity, especially for people
with bone metastases because of concerns over skeletal
complications. These recommendations provide a
framework and starting point for members of the
medical team and exercise professionals to improve the
integration of physical activity into the care of people
with bone metastases. It is anticipated that the recommendations provided here will continue to evolve as
more literature is available. Fundamental limitations
remain around a lack of deﬁnitive literature on standardized approaches to predict the risk of skeletal
complications and a paucity of data on the safety and
efﬁcacy of exercise for speciﬁc people that may be at
increased risk of skeletal complications with exercise
(ie, elderly individuals with multiple myeloma).
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abstract

PURPOSE Exercise has been underutilized in people with advanced or incurable cancer despite the potential to
improve physical function and reduce psychosocial morbidity, especially for people with bone metastases
because of concerns over skeletal complications. The International Bone Metastases Exercise Working Group
(IBMEWG) was formed to develop best practice recommendations for exercise programming for people with
bone metastases on the basis of published research, clinical experience, and expert opinion.
METHODS The IBMEWG undertook sequential steps to inform the recommendations: (1) modiﬁed Delphi survey,
(2) systematic review, (3) cross-sectional survey to physicians and nurse practitioners, (4) in-person meeting of
IBMEWG to review evidence from steps 1-3 to develop draft recommendations, and (5) stakeholder
engagement.
RESULTS Recommendations emerged from the contributing evidence and IBMEWG discussion for pre-exercise
screening, exercise testing, exercise prescription, and monitoring of exercise response. Identiﬁcation of individuals who are potentially at higher risk of exercise-related skeletal complication is a complex interplay of these
factors: (1) lesion-related, (2) cancer and cancer treatment–related, and (3) the person-related. Exercise
assessment and prescription requires consideration of the location and presentation of bone lesion(s) and
should be delivered by qualiﬁed exercise professionals with oncology education and exercise prescription
experience. Emphasis on postural alignment, controlled movement, and proper technique is essential.
CONCLUSION Ultimately, the perceived risk of skeletal complications should be weighed against potential health
beneﬁts on the basis of consultation between the person, health care team, and exercise professionals. These
recommendations provide an initial framework to improve the integration of exercise programming into clinical
care for people with bone metastases.
JCO Oncol Pract 18:e697-e709. © 2022 by American Society of Clinical Oncology
Creative Commons Attribution Non-Commercial No Derivatives 4.0 License
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People living with advanced or incurable cancers
are treated with sequential cancer therapies to
improve survival and quality of life, but treatment
burden can be high, including fatigue, reduced
physical function, and psychosocial morbidity.1 In
this context, people with advanced or incurable
cancer highlight that maintaining functional independence and managing symptom burden are top
priorities.2,3
Exercise (ie, planned and structured physical activity
aimed to improve health) has been shown to improve
fatigue, physical function, and psychosocial morbidity

in people with early-stage cancers.4 In the advanced or
incurable cancer setting, the presence of bone metastases complicates prescribing exercise and promoting physical activity because of concerns about
potential skeletal complications such as pathologic
fracture, hypercalcemia, or spinal cord compression.5
Although people with bone metastases regularly express an interest in information on exercise,6-8 health
care professionals report uncertainties regarding
risk management.9-11 Recent systematic reviews in
advanced or incurable cancer generally show exercise
to be safe, feasible, and beneﬁcial for quality of life,
physical function, and fatigue.12-18 However, these
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systematic reviews have not focused speciﬁcally on the safety
or efﬁcacy of exercise for people with bone metastases.
The International Bone Metastases Exercise Working Group
(IBMEWG) was formed on the basis of the recognition that
people with bone metastases could potentially beneﬁt from
exercise and are not receiving direction from the health
care team, as they may be reticent because of lack of
guidance in the literature or clinical practice. This group
aimed to develop best practice recommendations on the
basis of existing research evidence, clinical experience,
and expert opinion.
METHODS
The IBMEWG is a multidisciplinary, international panel of
physicians, physical therapists, clinical exercise physiologists, and researchers. Sequential steps (Fig 1) were taken
to inform the recommendations: (1) modiﬁed Delphi survey
to ascertain the practical considerations of implementing
exercise for people with bone metastases in the outpatient
oncology setting19 (all participants provided informed
consent, Research Ethics Board approval, University of
British Columbia; H19-00379); (2) systematic review to
assess the safety, feasibility, and efﬁcacy of exercise in
controlled trials that included people with bone metastases
(International Prospective Register of Systematic Reviews:
CRD42019121958)20; (3) cross-sectional survey to physicians and nurse practitioners to understand the attitudes
toward exercise for people with bone metastases and
components required to promote exercise referral21 (all
participants provided informed consent, Research Ethics
Board approval, University of British Columbia; H1900379); (4) in-person meeting of IBMEWG to review evidence from steps 1-3 to develop recommendations; and (5)
stakeholder engagement, ﬁrst with people with bone metastases (draft recommendations) and second with clinician peers (penultimate recommendations).
RESULTS
Recommendation 1
Before exercise testing or training, perform a risk assessment to inform the likelihood of a skeletal complication from
exercise.
The Delphi identiﬁed consensus on information that respondents deemed key to determine exercise suitability
(Table 1). However, reliance on an individual’s selfreported bone lesion details did not reach consensus. The
systematic review showed that randomized controlled trials
of exercise involving people with bone metastases commonly exclude people deemed to have structurally unstable
bone lesion(s) or pain associated with bone lesion(s).20
Determination of lesion stability was either undeﬁned22,23
or two randomized controlled trials used Taneichi’s subtype
A-C scoring for osteolytic thoracic and lumbar spine lesions, with computed tomography or magnetic resonance

imaging assessed independently by a radiologist and orthopedic surgeon.24,25 In the survey, most respondents
agreed that exercise for people with bone metastases was
safe (82%) and these individuals look to their health care
providers to provide exercise referral and recommendations (74%). To facilitate respondents providing an exercise
recommendation to individuals, the most frequently cited
resource identiﬁed was a set of clinical guidelines for exercise in this population (25%), an easy-to-use screening
scale (20%), and a consult with a qualiﬁed exercise professional (13%).21
The IBMEWG acknowledged that in the absence of literature, all people with bone metastases can be at risk of an
exercise-related skeletal complication, but this should not
preclude prescribing exercise. Identiﬁcation of individuals
who are potentially at higher risk of exercise-related
skeletal complication is a complex interplay of these
factors: (1) lesion-related, (2) cancer and cancer
treatment–related, and (3) person-related (Table 2).
Furthermore, it was acknowledged that bone scan reports
may not consistently provide information on lesion volume
and that a computed tomography and magnetic resonance imaging may be more reliable for structural qualities of the bone and preferable for people deemed higher
risk. Finally, more research is required to conﬁrm the
utility of pre-exercise skeletal assessment scales to guide
risk assessment. Stakeholders with bone metastases reported that they were keen to exercise but fearful, lacking
in conﬁdence for self-guidance, and uncertain where to
look for exercise advice. They conﬁrmed that discussion
with the health care team on how to manage risk was of
key interest to people with bone metastases.
Recommendation 2
Consultation with the medical team is strongly encouraged
before an exercise professional provides structured exercise for a person with bone metastases, to obtain key
medical information and establish bidirectional communication for initial assessment and exercise training
throughout care.
The primary reason reported by exercise professionals to
seek medical clearance or guidance was to obtain key
medical information, such as results of bone scan reports to
guide exercise prescription and to establish two-way
communication (ie, to allow for information sharing with
the goal of better safety and overall care). When asked if a
primary reason for seeking medical clearance or guidance
was a requirement for professional liability (ie, signed approval by a physician), only 39% of exercise professionals
strongly agreed or agreed (Table 1). In the systematic review, 24% of trials required medical clearance by a physician. For the remainder, exclusion criteria speciﬁc to
lesion characteristics of bone metastases were used, such
as excluding people with unstable bone metastases (24%)
or pain associated with the bone lesion (41%).20 Most
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Preliminary planning meeting
(held as informal side meeting of attendees at the annual meeting 2018 American College of Sports Medicine; n = 16)

Modified Delphi consensus process
(participants, n = 73 [R1], 59 [R2], 57 [R3])

Systematic review
(No. of trials included, n = 17)

Inclusion criteria
Involved with research that used a mode of exercise and
involved participants with bone metastases; OR
Exercise or health care professional who has worked with a
minimum of 10 people with bone metastases per year; OR
Considered expert in exercise and bone metastases
through clinical or research experience

Inclusion criteria
Randomized controlled or controlled clinical trials
Adults (≥ 18 years) with cancer diagnosis and included
people with bone metastases
Exercise intervention (> 1 session structured exercise)
Outcome: physical function, functional capacity, muscular
strength, or treatment side effect

Inclusion criteria
Physician and nurse practitioner survey
(participants and physicians, n =109;
nurse practitioners, n = 15)

In-person meeting of the International
Bone Metastases Exercise Working
Group and recommendation
development (participants = 21)

Providing care for people with metastatic cancer in publicly
funded provincial cancer service in British Columbia, Canada
AND
Oncologists (medical, radiation, and surgeons) OR
General practitioners in oncology OR
Nurse practitioner

Inclusion criteria
Previous research expertise in exercise oncology,
particularly in advanced cancer or bone metastases; OR
Clinicians engaged in clinical oncology care; AND
Willingness to attend 2-day meeting in-person or
virtually.

Draft recommendation statements by International Bone Metastases Exercise Working Group

Stakeholder engagement: People
with bone metastases (participants = 3)

Inclusion criteria
Person living with bone metastases > 1 year
Experience in engaging in exercise
Able to attend in-person focus group

Update of recommendations statements and draft of rationale statements by smaller working group
(D.S.M., J.G., K.A.B., K.L.C., K.M.W.S., M.L.M., N.H.H., P.C., S.W.)

Stakeholder engagement: clinician peers
(participants = 5)

Inclusion criteria
Exercise or health care professional who has
experience in working with people with bone metastases

Finalization of recommendations by International Bone Metastases Exercise Working Group

FIG 1. Information gathering and recommendation development process.

survey respondents agreed that people with bone metastases expected their physician to provide physical activity
recommendations (74%), and these recommendations
would be well received (66%) and followed (58%). However, less than half of the physicians and nurse practitioners
(43%) felt conﬁdent to recommend exercise to people with
bone metastases.21

for health care providers to feel that they have enough
understanding of exercise to provide medical clearance
and for exercise professionals to obtain or interpret all the
desired clinical information to assess risk, especially
without access to the medical chart (Appendix Table A1,
online only).

The IBMEWG agreed that the term medical consultation
versus clearance was the most appropriate term for
communication between the exercise professional and
health care provider. The goal of such medical consultation
is to establish two-way communication to assess the cost to
beneﬁt-risk of an exercise prescription, as it can be difﬁcult

Recommendation 3
Exercise professionals best suited to prescribe exercise to
people with bone metastases are physical therapists and
clinical exercise physiologists (or equivalent), who have
additional cancer exercise training and appropriate experience in working with people with a cancer diagnosis.
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TABLE 1. Modiﬁed Delphi Survey Results and Future Research Directions
DR

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Consensus (%)

A. Pre-exercise screening questions (Recommendation 1)
DR2

When performing a pre-exercise screening on an individual with MBD, it is STRONGLY RECOMMENDED that an exercise professional
uses the following information to determine exercise suitability: (1) bone lesion details, ideally from a diagnostic report that includes
lesion location, type, progression, and history; (2) bone pain details (during rest, ADLs, or physical activity); (3) any medical treatment for
bone pain within the past 3 months; (4) symptoms associated with the bone lesions
91%

9%

0%

0%

0%

100% agree

DR2

In addition to the above items, when performing a pre-exercise screening on an individual with MBD, it is STRONGLY RECOMMENDED
that an exercise professional also uses the following information to determine exercise suitability: (1) detailed medical history, (2) current
medications or treatments speciﬁc to MBD or pain, (3) history of fractures and falls, (4) bone mineral density report, (5) the individuals’
physical activity goals, and (6) current physical activity levels

DR2

In the absence of a bone scan report (or a similar diagnostic report or letter from medical doctor), an individual’s self-reported details of the
bone lesion(s) ARE SUFFICIENT

86%

12%

2%

2%

14%

23%

0%

35%

0%

26%

98% agree

No consensus reached

B. Medical clearance and Medical guidance (Recommendation 2)
DR3

As an exercise professional, the primary objective when seeking a medical clearance or medical guidance from a physician, in relation to
an individual with MBD is
a. Medical information (eg, reports from recent scans or tests and any upcoming treatments)
65%

28%

5%

0%

2%

93% agree

7%

16%

2%

76% agree

b. Establish two-way communication
53%

23%

c. Recommendations for exercise prescription
10%

23%

23%

33%

11%

No consensus reached

27%

12%

33%

16%

No consensus reached

d. Professional liability
12%
DR3

Individuals with MBD who meet any of the following conditions REQUIRE medical guidance from the individual’s medical professional prior
to commencing a structured exercise program with a clinical exercise professional: (1) bone lesions that are unstable or of unknown
stability, (2) bone pain or medical treatment of bone pain in the past 3 months, and (3) history of disease-related fractures within the past
12 months
63%

26%

2%

5%

4%

89% agree

C. Suitable exercise professionals (Recommendation 3)
DR2

Please select all the exercise professionals that you feel are suitable to safely prescribe exercise to an individual with metastatic bone
disease who is deemed HIGHER RISK OF FRACTURE (eg, multiple bone lesion locations, unknown stability, and symptomatic)
a. Physical therapist

39

b. Physical therapist with cancer exercise training

95

c. Exercise physiologist

20

d. Exercise physiologist with cancer exercise training

85

e. Kinesiologist or exercise or sports scientist or exercise therapist

13

f. Kinesiologist or exercise sports scientist or exercise therapist with cancer exercise training

52

g. Personal trainer

0

h. Personal trainer with cancer exercise training

13

i. Fitness instructor

0

j. Fitness instructor with cancer exercise training

7

(continued on following page)
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TABLE 1. Modiﬁed Delphi Survey Results and Future Research Directions (continued)
DR

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

DR2

In an individual with MBD who is at a LOWER risk of fracture, I recommend exercise testing,
but there are some tests that are contraindicated

Consensus (%)

D. Exercise testing (Recommendation 4)

70%

30%

70% agree

In an individual with MBD who is at a HIGHER risk of fracture, I recommend exercise testing, but there are some tests that are
contraindicated
88%
DR3

12%

88% agree

When considering strength testing for a person with bone metastases, I would
a. Avoid any strength testing (7%)
b. Avoid any strength testing that places stress on the lesion site (44%)
c. Use caution with any testing that places stress on the lesion site (37%)
d. Not make any considerations (7%)
e. I am not an exercise professional and do not feel I can answer this question (2%)
E. Exercise prescription (Recommendation 5)

DR2

If an individual is deemed UNSAFE TO EXERCISE (aka “high” risk), it is appropriate for an exercise professional to provide physical activity
education or movement prescription that is modiﬁed to speciﬁcally suit the individual and is provided in collaboration with the
individuals’ medical team

DR3

Once an individual with MBD has received an exercise prescription from a highly qualiﬁed exercise professional (eg, Physiotherapist or
Exercise Physiologist with cancer exercise training), referral to a less qualiﬁed exercise professional (eg, Personal Trainer or Fitness
Instructor) may be appropriate. The less qualiﬁed exercise professional would administer and monitor the speciﬁc exercise program
established by the Physiotherapist or Exercise Physiologist

65%

26%

16%
DR3

49%

12%

4%

16%

4%

7%

91% agree

No consensus reached

For individuals with lower risk MBD (eg, stable and asymptomatic), exercise prescription is normally safe if it USES CAUTION with exercises
that place stress on the bone lesion site
54%

DR3

2%

39%

5%

0%

2%

93% agree

What does the term “use caution” mean to you, in the context of the question above?
a. Start by avoiding any exercises that place stress on the lesion site (14%)
b. For exercises that target the lesion site, start with active movement and no load or weight and progress slowly, provided there is no
exacerbation of pain or adverse symptoms (47%)
c. For exercises that target the lesion site, start with low loads (eg, theraband or light dumbbells) and progress slowly, provided there is no
exacerbation of pain or symptoms (28%)
d. Other (10%)
F. Direction for future exercise research for people with bone metastases
Clinical prediction models for adverse event risk during physical activity
In exercise studies of people with advanced cancer, report in detail for people with bone metastases
a. Numbers of participants
b. Lesion(s) details: type, location, size, and treatments
c. Screening procedures, tools, or decision-making process
d. Adaptations to testing and exercise protocols
e. Adverse events related and unrelated to exercise
Conduct studies of safety and efﬁcacy that test
a. Different exercise prescription approaches
b. Use of established scales or tools to screen or inform exercise prescription
c. Exercise dose that optimizes maintenance or improvement on target outcome
d. Exercise for individuals with unstable or painful bone lesion(s)
Qualitative analysis of people with bone metastases perceptions of exercise, particularly safety, beneﬁt, and worry

Abbreviations: ADL, activity of daily living; DR, Delphi Round; MBD, metastatic bone disease.
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TABLE 2. Recommendation for Team-Based Approach to Provision of Exercise Programming to People Living With Bone Metastases
Medical communication
Communication with current medical team (eg,
Oncologist) is recommended to

Obtain any necessary medical guidance or additional information (eg, speciﬁc bone lesion details, previous
and current cancer therapies, etc)
Establish and maintain a two-way communication pathway to share information on
New presentation of pain
Other symptoms
Functional concerns

Access to information on lesion-speciﬁc factors

Most recent bone scan report or other diagnostic report that describes the following:
Type of lesion (osteolytic, sclerotic, or mixed)
Number of lesion (s)
Location of lesion(s) (ie, load-bearing areas such as femur, spine, pelvic ring, acetabulum, and tibial
plateau)
Size of lesion(s) (ie, small v large)
Series of reports to determine status of the lesion(s), rate of progression, and structural stability of bone (ie,
any evidence of vertebral compression)
Pre-exercise history

Cancer and cancer treatment–related factors to consider
Cancer diagnosis

Prognosis or progression of disease
Metastases to other organ systems (ie, brain and lung)
History of fractures since cancer diagnosis

Management of bone metastases

Planned or prior treatment approach to management of bone metastases (ie, surgical, radiation, and
medical)
Planned or prior treatment approach to management or for SSE (ie, surgical, radiation, and medical)
Current use of bone agents (eg, denosumab and bisphosphonates . 6 months)
Current use of agents that may increase risk of SSE (ie, corticosteroids, hormonal therapy, and
anticoagulants)

General bone health

Bone health risk factors (ie, smoking and family history of osteoporosis)
Diagnosis and severity of osteoporosis
Pharmaceutical management of osteoporosis (eg, bisphosphonates)

Pain

Severity
Location
Use of pain medication related to site of lesion(s)
Triggers (eg, functional pain, during ADLs, loading, at rest, and at night)
Change in quality or location of pain (ie, new pain with weight bearing, transitional pain when performing
ADLs, and pain worsening at night)

Neurologic

Sudden or recent muscle weakness in any region
Sudden, new or recent change in bowel and/or bladder control (ie, progressive urinary retention, bladder or
bowel incontinence)
New or progressive gait or balance impairment
Loss of sensation or reﬂexes in any region

Falls

Occurrence within the past 12 months
If positive, number of falls
If positive, injuries consequent to fall

Person-related factors to consider
Overall medical and symptom proﬁle (eg, comorbid condition, fatigue, and cachexia)
Worse ECOG PS
Limitations in ADLs or instrumental ADLs
Cognitive impairment (eg, making adherence to precautions unreliable)
Exercise history

Abbreviations: ADL, activity of daily living; ECOG PS, Eastern Cooperative Oncology Group Performance Status; SSE, symptomatic skeletal event.
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The Delphi showed consensus that the exercise professionals best suited to prescribe exercise to people with
bone metastases were university qualiﬁed with clinical
expertise, namely, physical therapists (95% agree) and
clinical exercise physiologists (85% agree), provided that
each has additional cancer exercise education and
training (Table 1). In the systematic review, exercise supervision was provided predominantly by universitytrained exercise professionals, including physical therapists and clinical exercise physiologists. All but one trial
included at least one session of in-person supervised
exercise instruction (ie, individualized demonstration and
practice).20
The IBMEWG recommended that all people are assessed
by a physical therapist or clinical exercise physiologist,
with additional cancer exercise education and ideally
experience in working with people who have bone metastases (Appendix Table A1). This may necessitate that
exercise professionals initially are advised or supervised
by a more experienced colleague, and these recommendations may need to be adapted in different jurisdictions and clinical settings. Stakeholders with bone
metastases endorsed the importance of members of the
health care team being able to guide people to qualiﬁed
professionals. The IBMEWG highlighted that considerable
work is needed to establish a referral pathway to improve
equitable access to qualiﬁed exercise professionals. Each
exercise professional must consider their own training and
experience, as well as the setting in which they work, to
determine if it is appropriate to work with that client or to
refer. Finally, the results of the systematic review suggest
that an element of supervised exercise instruction should
be initially included before the addition of unsupervised
exercise for individuals with bone metastases. Although
this supports the potential feasibility of delivering supervised virtual exercise programs in light of the COVID-19
pandemic, research is needed to determine the overall
safety proﬁle of virtual exercise for individuals with bone
metastases.26
Recommendation 4
Professional judgment should be used to consider if exercise testing at baseline and follow-up is necessary by
weighing the risks and beneﬁts of including the test or if the
testing protocols may need to be modiﬁed.
In the Delphi, for lower and higher risk examples, the
statement that “exercise testing was recommended but
there were some tests that were contraindicated” met
consensus. Speciﬁc to strength testing, there was consensus to avoid tests or use caution with a test that places
stress on a lesion site (Table 1). In the systematic review,
few studies provided sufﬁcient details on which participants
completed the tests outlined in the methods and why a test
may or may not be used for select participants. For the four
studies exclusively in people with bone metastases, all

outlined speciﬁc adjustments to the testing protocol.20 For
example, Galvao et al27 excluded people with metastatic
bone lesion(s) in the proximal femur from completing the
1-RM leg press and 400-m walk tests, and people with lesions
in ribs, thoracic spine, or humerus were excluded from
completing the 1-RM chest press and 1-RM seated row.
The IBMEWG assessed that there was insufﬁcient evidence
to guide speciﬁc recommendations on a standardized
approach for safe exercise testing. To provide additional
expert guidance, the recommendation is to focus on the
goal of exercise testing and to follow the testing guidance in
the International Exercise Guidelines for Cancer Survivors4
until further evidence is available to update this approach
(Appendix Table A1). In addition, exercise practitioners
should use professional judgment to consider if a test
is necessary and consistent with the person’s goals, while
providing written justiﬁcation for inclusion of the test as
part of the treatment plan in an appropriate charting
location.
Recommendation 5
Exercise prescription should follow the standard exercise
recommendations as outlined by the International Exercise
Guidelines for Cancer Survivors, with greater emphasis on
postural alignment, controlled movement, and proper
technique, as well as consideration given to the location
and presentation of the bone lesion(s). Formal monitoring
of exercise response and adjustment of exercise prescription should be ongoing.
The Delphi shows a 91% consensus that education and
advice on safe movement patterns for activities of daily
living is important for all people with bone metastases
(Table 1). Speciﬁc to prescribing an exercise that could
directly place stress on the lesion site, most respondents
agreed that the correct approach was to use caution.
Respondents deﬁned this as “start with active movement
and no load or weight and progress slowly, provided there is
no exacerbation of pain or adverse symptoms” (47%) or
“start with low loads and progress slowly, provided there is
no exacerbation of pain or adverse symptoms (28%).” This
is a notable departure from approaches outlined originally
by Cormie et al28 and Galvao et al,27 in which exercise
involving the affected bone region was avoided altogether.
In the systematic review, exercise prescription modiﬁcations speciﬁc to the presence of bone metastases were
included in 41% of trials, whereas the remainder of trials
did not report exercise modiﬁcations speciﬁc to bone
metastases. How a participant’s response to exercise was
monitored and the related adjustments made to the exercise prescription were not uniformly reported.20
The IBMEWG discussed the available literature that could
be used to inform speciﬁc guidance around exercise
prescription approaches. Exercise prescription for resistance exercises that prevent direct stress on the site of bone
lesions has been published by IBMEWG members (P.C.,
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N.H.H., and R.U.N.).27,28 It was acknowledged that these
previously published approaches were conservative and
provided a starting point, while evidence regarding safety
continued to emerge. The challenge in applying these
generic prescription approaches is that individuals with
widespread metastatic disease may be recommended to
engage in limited exercise options that do not target the
overall function or the goals of the individual. The approved
movements can also be more restrictive than many activities of daily living that place considerable load on the
body, including sites of bone metastases, such as
descending stairs.
The IBMEWG recommendation aims to move beyond the
initial and restrictive approaches to exercise testing and
prescription with the goal better informing the development
of efﬁcacious exercise prescriptions for people with bone
metastases in the clinical setting. The standard approach to
exercise prescription for people living with and beyond
cancer as outlined by the International Exercise Guidelines
for Cancer Survivors from the American College of Sports
Medicine4 should be used, with ongoing monitoring of
individual response to adjust the exercise prescription or to
send the person for further review. It was also deemed
important to take additional guidance from exercise literature in osteoporosis that has sought to reduce the risk of
skeletal-related complications, especially in vertebral
bodies and hip.29,30 This includes an emphasis on correct
technique and postural alignment with all exercises;
avoidance of rapid or loaded end-range movements, such
as rotation, ﬂexion, or extension movements that involve the
area of the lesions; consideration of impact loading of an
exercise along with the type of movement (ie, concentric,
eccentric, and plyometric) in the area of the bone lesion(s);
and education and precautions to minimize the risk of falls.
An additional consideration is that people with bone metastases may be deconditioned, because of treatment or
higher symptom burden, and exercise volume should be
adjusted accordingly.
Overarching Recommendation
Regular exercise has the potential to maintain or improve
physical function and health-related quality of life in people
with bone metastases, and the perceived risk of skeletal
complication should be weighed against the potential
health beneﬁts.
On the basis of the review of available evidence and expert
consensus, the IBMEWG has concluded that people with
bone metastases should be supported and encouraged to
engage in physical activity, including structured exercise, to
obtain the well-established general health beneﬁts, as a
strategy to manage side effects related to cancer and
treatments.4 Overall, the perceived risk of skeletal complications should be weighed against the potential health
beneﬁts of regular physical activity, including prevention of
further loss of functional capacity. Exercise professionals

should communicate with the health care team to minimize
participant risk while providing sufﬁcient exercise stimulus
to improve or maintain function or to slow decline, while
prioritizing the goals of the person. The IBMWG also
identiﬁed research priorities to allow for the continuous
evolution of evidence-based guidelines (Table 1).
This recommendation was strongly endorsed by our
stakeholders, both people with bone metastases and clinician peers, who felt it essential for members of the health
care team to initiate a conversation about exercise, explain
why exercise is important for people with bone metastases,
and frame exercise as a range of activities, spanning from
activities of daily living to sports. Stakeholders with bone
metastases also highlighted the need to increase the
availability of exercise services led by qualiﬁed exercise
professionals and the provision of more information on how
to access services.
DISCUSSION
These recommendations aim to provide a framework for
improved integration of exercise programming into the care
of people with bone metastases. The overarching recommendation is that routine exercise has the potential to
improve or maintain physical function and quality of life and
reduce treatment side effects, while also potentially increasing resilience for future treatments. To achieve provision of exercise programming, a collaborative relationship
between the health care team and qualiﬁed exercise
professionals is optimal. This approach is intended to
improve the health care team’s conﬁdence in encouraging
people with bone metastases to engage in regular exercise
and provide navigation on how to access qualiﬁed exercise
professionals who can develop appropriate and individualized exercise programming.
Determining the ideal approaches to pre-exercise
screening, exercise testing, and exercise programming
related to safety and skeletal-related events (SREs) remains
a challenge. The IBMEWG recommends that exercise
programming for people with bone metastases is administered by qualiﬁed exercise professionals, namely, physical therapists and clinical exercise physiologists, who have
additional training and experience in working with people
with a cancer diagnosis. These exercise professionals have
university-level training (or equivalent) in most countries
and a scope of practice that includes working with individuals with complex medical conditions.
A speciﬁc risk stratiﬁcation tool to evaluate the appropriateness of exercise participation for an individual is desired
by the health care team, exercise professionals, and people
with bone metastases. However, the utility to apply existing
screening tools used to predict the risk of fracture or guide
decisions on prophylactic surgical ﬁxation (ie, Taneichi,
Mirels, and Spinal Instability Neoplastic Score31) within the
exercise screening process for people with bone metastases
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is unknown. These have not been trialed extensively as part
of the pre-exercise screening process to date and cannot be
scored independently by an exercise professional. More
research into the practical use of such a screening tool or
newly developed tool is needed to determine if a standardized approach is feasible. Confounding this issue, the
initial detection of bone metastasis is evolving with the advent
of new imaging modalities. Unlike soft tissue tumors where
Response Evaluation Criteria in Solid Tumors are clear, the
response of bone metastasis to cancer treatment remains
poorly understood.32 A recently proposed algorithm for the
investigation of bone metastasis was proposed by the European Society for Medical Oncology in 2020, and this could
be considered for future exercise studies.32
The impact of cancer therapy and bone-modifying agents
(BMA) on bone remodeling remains an area of intense
study. With respect to BMA, zoledronic acid remains to date
the only bisphosphonate to show broad efﬁcacy in reducing
SREs in people with bone metastases from almost all
malignancies (including lung carcinoma and other solid
tumor types: prostate, breast, thyroid, head and neck,
thyroid, and renal cell).32 Data also show decreased SREs
with the use of RANK ligand inhibitors (denosumab) for
cancers of the prostate, breast, and renal cell, non–smallcell lung cancer, and multiple myeloma.32 In the future, the
use of BMA should be clearly documented in exercise
studies to develop a better understanding of their potential
inﬂuence on bone remodeling. Furthermore, future studies
should explore the use of bone biomarkers and imaging,
especially positron emission tomography in exploring

potential risk indicators and treatment response of exercise
interventions.
A key strength of the IBMEWG was the process to merge a
systematic understanding of the current literature with a
formalized Delphi process and stakeholder input. The
IBMEWG recommendations are consistent with two existing
publications. Sheill et al33 published a narrative review of
considerations for exercise prescription for people with
bone metastases, and the support organization Macmillan
Cancer Support in the United Kingdom developed a
user-friendly guidance document for health care professionals.34 The IBMEWG aimed to address gaps in these
documents by documenting the speciﬁc information
gathering and decision-making processes used to generate
the recommendations.
A fundamental limitation is a lack of deﬁnitive literature on
standardized approaches to safety screening, exercise
testing and prescription, and safety reporting of minor or
major complications with exercise, including between exercise sessions (ie, pain, disability, and need for analgesia).
In addition, there is a paucity of data on speciﬁc individuals
that may be at increased risk of fracture with exercise (ie,
elderly individuals with multiple myeloma).
In conclusion, these recommendations provide a framework
and starting point for exercise professionals and members of
the health care team to improved integration of physical
activity into the care of individuals with bone metastases. It is
anticipated that the recommendations provided here will
continue to evolve as more literature is available.
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APPENDIX

TABLE A1. Guidance for Exercise Testing Approach and Monitoring Exercise Response With Examples of Qualiﬁed Exercise Professionals
Guidance for exercise testing approach
Is the test necessary?

Consideration should be given to why the test is being conducted, weighing the risks against the beneﬁts, in
discussion with patient and healthcare team

Criteria for speciﬁc test selection:

Testing should inform clinical decision making and exercise prescription
Testing should be adapted according to patient goals
Individuals must be informed and feel comfortable to perform the test safely

Practical considerations

Avoid tests that place high loads on site(s) of bone metastasis (ie, 1-RM leg press for individual with lesion in
proximal femur or vertebrae)4
Consider potential of fall risk when using treadmill or other ambulatory machines (ie, handrails must be
available and blood pressure monitoring should be done with consideration of not compromising balance)
Consider forces testing approach on site(s) of bone metastasis (ie, eccentric concentric, or isometric,
including open v closed chain)
Consider the compressive forces of testing approach (ie, pressure on lumbar spine from backrest of leg
press machine or repeated chair rise causing rapid/forceful impact onto the chair)
Be mindful of movement and forces needed to get into position for tests not just the test itself (ie, range of hip
ﬂexion needed to get into position for leg press in a leg press machine) as this can inadvertently cause
unsafe movement related to risk of skeletal complication
Guidance for monitoring response to exercise training

Observation

Exercise professionals should continuously monitor overall response to each exercise prescribed and adjust
prescription as appropriate to reduce potential risk of exercise-related adverse event

Self-reported response

Exercise professionals must ask the individual before and after each session about
Paina

New or increased pain; or
Change in quality or location of pain; or
Unexplained pain; or
Change in pain medication (dose and/or type) prior to or
following an exercise session
Ideally using a standardized tool, such as a visual analog
scale

Neurological symptomsa

New symptom or change in symptom (eg, muscle
weakness, loss of sensation or change in bladder/bowel
function, balance or gait)

ADL

New limitation or change in limitations

Examples of qualiﬁed exercise professionals and cancer certiﬁcations
Professional titleb

Regulatory or professional body

Licensed or registered physical therapist or
physiotherapist

Colleges of Physical Therapy (State, Province, Specialist Certiﬁcation in Oncology from the American
or National)
Physical Therapy Association35

Examples of additional cancer training or certiﬁcations

Clinical Specialist from Canadian Physiotherapy
Association36
ACSM-CEP

ACSM

ACSM Cancer Exercise Trainer37
CanRehab38

CSEP-CEP

CSEP

Thrive Cancer and Exercise Training39

ESSA-AEP

ESSA

ExMedCancer40
Exercise Medicine Research Institute41

Or equivalent in a given jurisdiction

Abbreviations: ACSM, American College of Sports Medicine; ADL, activity of daily living; AEP, Accredited Exercise Physiologist; CEP, Clinical Exercise
Physiologist; CSEP, Canadian Society for Exercise Physiology; ESSA, Exercise and Sport Science Australia; RM, repetition maximum.
a
For individuals with complex presentation, exercise professional should consider asking the individual before and after each exercise performed,
especially if it is a new exercise.
b
There is currently no single standardized licensing examination or number of clinic hours identiﬁed as optimal credentials for exercise professionals,
speciﬁc to working with people with bone metastases.
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